Increased macrophage chemoattractant protein-1 in cerebrospinal fluid precedes and predicts simian immunodeficiency virus encephalitis

Journal of Infectious Diseases

Volumn 184, Issue 8, 2001, Pages 1015-1021

  Zink, M Christine ^a,b,d   Coleman, Gary D ^d   Mankowski, Joseph L ^a,b   Adams, Robert J ^a   Tarwater, Patrick M ^d   Fox, Kelly ^d   Clements, Janice E ^c  

^a Division of Comparative Medicine   (United States)

^b Department of Pathology ^*  (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CHEMOKINE; GLIAL FIBRILLARY ACIDIC PROTEIN; MACROPHAGE CHEMOTACTIC FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD BRAIN BARRIER; CENTRAL NERVOUS SYSTEM DISEASE; CEREBROSPINAL FLUID ANALYSIS; CONTROLLED STUDY; INFLAMMATORY CELL; MACACA; MACROPHAGE ACTIVATION; NONHUMAN; PREDICTION; PRIORITY JOURNAL; RECEPTOR UPREGULATION; SIMIAN IMMUNODEFICIENCY VIRUS; VIRUS ENCEPHALITIS; VIRUS GENE; VIRUS REPLICATION;

ANIMALS; BRAIN; BRAIN CHEMISTRY; CHEMOKINE CCL2; DISEASE MODELS, ANIMAL; ENCEPHALITIS, VIRAL; HUMANS; IMMUNOHISTOCHEMISTRY; MACACA; PREDICTIVE VALUE OF TESTS; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS;

EID: 0035887671     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/323478     Document Type: Article

References (42)

1. HIV-associated neurologic disease incidence changes: Multicenter AIDS Cohort Study, 1990-1998
2. Neuropathology of human immunodeficiency virus infection
3. Dementia in AIDS patients: Incidence and risk factors
4. Human immunodeficiency virus and the central nervous system
5. Levels of human immunodeficiency virus type 1 RNA in cerebrospinal fluid correlate with AIDS dementia stage
6. Cerebrospinal fluid HIV-1 RNA levels: Correlation with HIV encephalitis
7. Neurological disorders during HIV-1 infection correlate with viral load in cerebrospinal fluid but not with virus phenotype
8. Cerebrospinal fluid human immunodeficiency virus type 1 RNA levels are elevated in neurocognitively impaired individuals with acquired immunodeficiency syndrome
9. Relationship between human immunodeficiency virus-associated dementia and viral load in cerebrospinal fluid and brain
10. Immunocytochemical quantitation of human immunodeficiency virus in the brain: Correlations with dementia
11. The brain in AIDS: Central nervous system HIV-1 infection and AIDS dementia complex
12. Chemokines and activated macrophages in HIV gp120-induced neuronal apoptosis
13. Human immunodeficiency virus type 1 infection of the nervous system: Pathogenetic mechanisms
14. Neuronal excitatory properties of human immunodeficiency virus type 1 Tat protein
15. Human immunodeficiency virus type 1 tat activates non-N-methyl-D-aspartate excitatory amino acid receptors and causes neurotoxicity
16. Identification of a human immunodeficiency virus type 1 Tat epitope that is neuroexcitatory and neurotoxic
17. Central nervous system damage produced by expression of the HIV-1 coat protein gp120 in transgenic mice
18. Receptors, signal transduction, and spectrum of action of monocyte chemotactic protein-1 and related chemokines
19. Monocyte chemoattractant protein 1: A potential regulator of monocyte recruitment in inflammatory disease
20. Controlled recruitment of monocytes and macrophages to specific organs through transgenic expression of monocyte chemoattractant protein-1
21. Defects in macrophage recruitment and host defense in mice lacking the CCR2 chemokine receptor
22. Chemokine and chemokine-receptor expression in human glial elements: Induction by the HIV protein, tat, and chemokine autoregulation
23. Induction of monocyte chemoattractant protein-1 in HIV-1 Tat-stimulated astrocytes and elevation in AIDS dementia
24. Elevated cerebrospinal fluid levels of monocyte chemotactic protein-1 correlate with HIV-1 encephalitis and local viral replication
25. Betachemokines MCP-1 and RANTES are selectively increased in cerebrospinal fluid of patients with human immunodeficiency virus-associated dementia
26. High viral load in CSF and brain correlates with severity of SIV encephalitis
27. Pathogenesis of SIV encephalitis: Selection and replication of neurovirulent SIV
28. Analysis of envelope changes acquired by SIVmac239 during neuroadaption in rhesus macaques
29. Molecular and biological characterization of a neurovirulent molecular clone of SIV
30. Pathogenesis of SIV encephalitis: Viral determinants of neurovirulence
31. Derivation of neurotropic SIV from exclusively lymphocyte-tropic parental virus: Pathogenesis of infection in macaques
32. Genotypic selection of simian immunodeficiency virus in macaque infants infected transplacentally
33. Pathogenesis of acute infection in rhesus macaques with a lymphocyte-tropic strain of simian immunodeficiency virus
34. Induction of AIDS by simian immunodeficiency virus from an African green monkey: Species-specific variation in pathogenicity correlates with the extent of in vivo replicaiton
35. Astrocyte expression of mRNA encoding cytokines IP-10 and JE/MCP-1 in experimental autoimmune encephalomyelitis
36. Localization of monocyte chemoattractant peptide-1 expression in the central nervous system in experimental autoimmune encephalomyelitis and trauma in the rat
37. Role of secretion and bulk flow of brain interstitial fluid in brain volume regulation
38. Anatomical pathways for lymphatic drainage of the brain and their pathological significance
39. Expression of MCP-1 by reactive astrocytes in demyelinating multiple sclerosis lesions
40. Chemokines and chemokine receptors in inflammation of the nervous system: Manifold roles and exquisite regulation
41. Role of chemokines, neuronal projections, and the blood-brain barrier in the enhancement of cerebral EAE following focal brain damage
42. Serum and CSF levels of MCP-1 and IP-10 in multiple sclerosis patients with acute and stable disease and undergoing immunomodulatory therapies